Document is current
Any future updates will be listed below
-
Authors
Dingli, Sarah
Rothweiler, Paul
Binder, Moritz https://orcid.org/0000-0001-9014-9658
Cook, Joselle https://orcid.org/0000-0001-5335-9533
Gertz, Morie A.
Hayman, Suzanne
Kapoor, Prashant https://orcid.org/0000-0002-4342-364X
Kourelis, Taxiarchis https://orcid.org/0000-0001-8573-9434
Kumar, Shaji K. https://orcid.org/0000-0001-5392-9284
Siddiqui, Mustaqeem https://orcid.org/0000-0002-4640-7311
Warsame, Rahma
Lin, Yi https://orcid.org/0000-0002-1556-6416
Erdman, Arthur G.
Dingli, David https://orcid.org/0000-0001-7477-3004
- License Information
-
More Information
Article History
Received: 8 January 2025
Revised: 17 March 2025
Accepted: 2 April 2025
First Online: 7 May 2025
Competing interests
: SD, PR, MB, JC, SH, MS, RW, and AGE have no disclosures. MAG: Personal fees from Ionis/Akcea, honorarium from Alnylym, personal fees from Prothena, personal fees from Sanofi, personal fees from Janssen, personal fees for Data Safety Monitoring board from Abbvie & Arcellex, fees from Johnson & Johnson, Honoraria from Astra Zeneca, Medscape, Dava Oncology. Alexion and NCI SPORE MM SPORE 5P50 CA186781-04. PK: Clinical trial support with research funding to the institution from Amgen, Regeneron, Bristol Myers Squibb, Loxo Pharmaceuticals, Ichnos, Karyopharm, Sanofi, AbbVie and GlaxoSmithKline. Honorarium from Keosys and served on the Advisory Boards of BeiGene, Mustang Bio, Janssen, Pharmacyclics, X4 Pharmaceuticals, Kite, Oncopeptides, Ascentage, Angitia Bio, GlaxoSmithKline, Sanofi and AbbVie. TK: Research funding to institution: Pfizer. SKK: Consulting with no personal payment: AbbVie, Amgen, ArcellX, Beigene, BMS, Carsgen, GSK, Janssen, K36, Moderna, Pfizer, Regeneron, Roche-Genentech, Sanofi, Takeda, (with personal payments): CVS Caremark, BD Biosciences. Clinical trial support to institution - AbbVie, Amgen, Astra Zeneca, BMS, Carsgen, GSK, Gracell Bio, Janssen, Oricell, Roche-Genentech, Sanofi, Takeda, Telogenomics. YL: Ad Boards: Janssen, Sanofi, BMS, Regeneron, Genentech, Tessera, Legend, NexT Therapeutics. Steering Committees: Janssen, Kite/Gilead. Research: Janssen, BMS. Scientific Advisory Boards: NexImmune, Caribou. Data Safety Monitoring Board: Pfizer. DD: Consulting with personal payment: Alexion, Apellis, Argenyx, BMS, Janssen, Regeneron, Roche-Genentech, Sanofi, Sorrento and Takeda. Clinical trial support to institution: K36 Therapeutics.
